Sales decline 64.66% to Rs 21.68 crore
Net loss of Bharat Immunological & Biological Corporation reported to Rs 1.31 crore in the quarter ended March 2018 as against net profit of Rs 4.08 crore during the previous quarter ended March 2017. Sales declined 64.66% to Rs 21.68 crore in the quarter ended March 2018 as against Rs 61.34 crore during the previous quarter ended March 2017.For the full year,net loss reported to Rs 5.17 crore in the year ended March 2018 as against net profit of Rs 6.75 crore during the previous year ended March 2017. Sales declined 71.98% to Rs 34.80 crore in the year ended March 2018 as against Rs 124.19 crore during the previous year ended March 2017.
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales21.6861.34 -65 34.80124.19 -72 OPM %-19.7911.17 --24.519.90 - PBDT-4.056.00 PL -7.4910.04 PL PBT-4.105.99 PL -7.909.46 PL NP-1.314.08 PL -5.176.75 PL
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
